Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Engel, W. Eberlein, G. Mihm, R. Hammer, G. Trummlitz (1989)
Tricyclic compounds as selective muscarinic receptor antagonists. 3. Structure-selectivity relationships in a series of cardioselective (M2) antimuscarinics.Journal of medicinal chemistry, 32 8
T. Kelly, J. Proudfoot, D. Mcneil, U. Patel, E. David, K. Hargrave, P. Grob, M. Cardozo, A. Agarwal, J. Adams (1995)
Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 5. 4-Substituted and 2,4-disubstituted analogs of nevirapine.Journal of medicinal chemistry, 38 24
W. Eberlein, G. Trummlitz, W. Engel, G. Schmidt, H. Pelzer, N. Mayer (1987)
Tricyclic compounds as selective antimuscarinics. 1. Structural requirements for selectivity toward the muscarinic acetylcholine receptor in a series of pirenzepine and imipramine analogues.Journal of medicinal chemistry, 30 8
Fuqiang Shi, Xianxiu Xu, Lianyou Zheng, Q. Dang, X. Bai (2008)
Method development for a pyridobenzodiazepine library with multiple diversification points.Journal of combinatorial chemistry, 10 2
J. Liégeois, L. Eyrolles, B. Ellenbroek, C. Lejeune, P. Carato, J. Bruhwyler, J. Géczy, J. Damas, J. Delarge (2002)
New pyridobenzodiazepine derivatives: modifications of the basic side chain differentially modulate binding to dopamine (D(4.2), D(2L)) and serotonin (5-HT(2A)) receptors.Journal of medicinal chemistry, 45 23
J. Proudfoot, K. Hargrave, S. Kapadia, U. Patel, K. Grozinger, D. Mcneil, E. Cullen, M. Cardozo, L. Tong, T. Kelly (1995)
Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. 4. 2-Substituted dipyridodiazepinones as potent inhibitors of both wild-type and cysteine-181 HIV-1 reverse transcriptase enzymes.Journal of medicinal chemistry, 38 24
A. Failli, J. Shumsky, R. Steffan, T. Caggiano, David Williams, E. Trybulski, X. Ning, Y. Lock, T. Tanikella, D. Hartmann, P. Chan, C. Park (2006)
Pyridobenzodiazepines: a novel class of orally active, vasopressin V2 receptor selective agonists.Bioorganic & medicinal chemistry letters, 16 4
Douglas Horton, G. Bourne, M. Smythe (2003)
The combinatorial synthesis of bicyclic privileged structures or privileged substructures.Chemical reviews, 103 3
J. Klunder, K. Hargrave, M. West, E. Cullen, K. Pal, M. Behnke, S. Kapadia, D. Mcneil, J. Wu, G. Chow (1992)
Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinones.Journal of medicinal chemistry, 35 10
K. Hargrave, J. Proudfoot, K. Grozinger, Ernest Cullen, Suresh Kapadia, U. Patel, Victor Fuchs, S. Mauldin, J. Vitous, M. Behnke, J. Klunder, Kollol Pal, J. Skiles, Daniel McNeil, Janice Rose, Grace Chow, M. Skoog, Joe Wu, Günther Schmidt, Wolfhard Engel, Wolfgang Eberlein, T. Saboe, Scot Campbell, Alan Rosenthal, Julian Adams (1991)
Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones.Journal of medicinal chemistry, 34 7
J. Liégeois, J. Bruhwyler, J. Damas, T. Nguyen, E. Chleide, M. Mercier, F. Rogister, J. Delarge (1993)
New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study.Journal of medicinal chemistry, 36 15
J. Proudfoot, U. Patel, Suresh Kapadia, K. Hargrave (1995)
Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 3. Dipyrido[2,3-b:2',3'-e]diazepinones.Journal of medicinal chemistry, 38 8
W. Eberlein, W. Engel, G. Trummlitz, G. Schmidt, R. Hammer (1988)
Tricyclic compounds as selective antimuscarinics. 2. Structure-activity relationships of M1-selective antimuscarinics related to pirenzepine.Journal of medicinal chemistry, 31 6
A new one-pot Bischler–Napeiralski type cyclization reaction between pyridine-1,2-diamines and various carboxylic acids with PPA as catalyst to prepare pyridobenzodiazepines is proposed. In the new synthetic route, the reaction time is only one-third of the methods reported. The synthetic strategy provides an efficient way to prepare novel structurally diversified heterocyclic compounds of pyridobenzodiazepine family with potential pharmaceutical or biological activities.
Research on Chemical Intermediates – Springer Journals
Published: Mar 12, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.